Navigation Links
7,500 Cancer Cases Misdiagnosed in NSW

The NSW Department of Health in Australia has said that many cancer patients might have been misdiagnosed some five years ago. It is reported that 7,500 medical samples// analyzed in a Tamworth laboratory are involve in this case of wrong diagnosis.

An overseas-trained doctor was thought to have wrongly diagnosed the samples leading to some patients receiving unnecessary chemotherapy and some patients being denied potentially life-saving treatment. The tests were carried out between November 1999 and December 2001. Hunter New England Health said that it was not aware of what procedure to follow and has sought advice. "It's mainly pathology specimens that are taken during major and minor operations. It doesn't include blood tests, bone marrow tests, urine tests," said Chief executive of Hunter New England Health, Terry Clout. State health minister John Hatzistergos has expressed regrets about the whole situation, "I do sincerely regret any distress that has been caused to any person as a result of the actions that have been taken," he said. But state member for Tamworth Peter Draper says it is the fault of the bureaucracy. "I don't believe the bureaucrats who seem intent on covering their backsides should jeopardize people's health," Draper said.
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer Cases Misdiagnosed NSW

(Date:12/2/2008)..., Cost and Energy Efficient Information Infrastruc...re/ -- EMC Corporation (NYSE: EMC ), the world l...ay announced that the Daughters of Charity Health ...spanning the California coast, has consolidated st...ity functions to deliver new online clinical syste...
(Date:12/2/2008)...tal is now one of only two dental,practices in De...ment,Procedure). This is the only laser gum trea...for new attachment of gum and bone tissue around t...out removing healthy tissue, maintains,the height...scomfort to the,patient, closes the periodontal p...
(Date:12/2/2008)...umber of recent public research,studies substanti...s in,overweight children, and the questionable nu...onsume. Yet one manufacturer -- Funky Monkey(TM) ...ruit products that are not only fun,and convenien...the daily fruit,servings recommended by the U.S. ...
(Date:12/2/2008)...; Flu Companion uses location-based technology to .... , Scottsdale, Ariz. (PR..., makers of Zicam® Cold Remedy, today announce...anion mobile application for the T-Mobile G1&trade...me mobile application will be released for the iPh...
Breaking Medicine News(10 mins):Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 4Health News:Barotz Dental Now Offering Laser Gum Therapy 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3Health News:Zicam Launches "Cold & Flu Companion" Mobile Application 2Health News:Zicam Launches "Cold & Flu Companion" Mobile Application 3
...shington University verified the health benefits o...o assess the potential of both categories in the m...l levels and weight loss.// The study was conduct...ere half the group was asked to follow a low fat v...
...rating condition of a leprosy centre in the capita... for either relocation or reconstruction of the fa...undation and goodwill ambassador of World Health O...hen he visited the Satya Jeevan Kushta Ashram on J...
... of New Zealand is making certain changes to asthm...e changes are bound to benefit// a significant num...of the changes include widening the access to asth...easing the choice available to patients by introdu...
...l, West Sussex was prosecuted for intentionally in...as issued to arrest him.// He failed to appear a...h Crown Court that the 47-year-old businessman wou...ing a lengthy jail sentence for inflicting bodily ...
Other Medicine News:
(Date:12/1/2008)...re/ -- New research has found that the availabilit...T) scanner in an emergency room can significantly ...a potentially life-saving treatment. Results of th...NSMC)-Salem Hospital in Salem, Mass., will be pres...cal Society of North America (RSNA). , , "T...
(Date:12/1/2008)...BIO Pte Ltd today announced the initiation of a Ph...lly-active JAK2 inhibitor, in leading medical cent...hic myelofibrosis (CIMF). , , The trial is...of SB1518 in patients with CIMF and is expected to... study will assess the safety profile and evaluate...
(Date:12/1/2008)...olicy , , ROCHESTER, Minn., Dec. 1 /PRNews...inds the use of the drug therapy etanercept ineffe...flammation of the liver caused by excessive consum...lished in the December issue of Gastroenterology ...DEO ALERT: Additional audio and video resources, i...
(Date:12/1/2008)...l/ -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX...ng,human vaccines for diseases caused by HIV-1 (H... agents, announced today that the launch of its Ph...elve sites across North and South America.,These ...ional Institutes of,Health (NIH), and the HIV Vac...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 1BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 2BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 3BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 4Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 1Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 2Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 3Emageon Reports Third Quarter 2007 Financial Results 5593 1Emageon Reports Third Quarter 2007 Financial Results 5593 2Emageon Reports Third Quarter 2007 Financial Results 5593 3Emageon Reports Third Quarter 2007 Financial Results 5593 4Emageon Reports Third Quarter 2007 Financial Results 5593 5Emageon Reports Third Quarter 2007 Financial Results 5593 6Emageon Reports Third Quarter 2007 Financial Results 5593 7Emageon Reports Third Quarter 2007 Financial Results 5593 8Emageon Reports Third Quarter 2007 Financial Results 5593 9Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 1Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 2Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 3Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 4
...dest, Most Comprehensive Survey Provides New Bench... June 21, 2007 /PRNewswire-USNewswire/ -- The,foll... -- First nationwide study of the prevalence of ...s (MRSA), a virulent multi-drug resistant organism...MRSA prevalence study findings significantly excee...
... LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Neurol...ation in the June 23 issue,of the journal The Lanc...erapy trial for Parkinson,s disease and the first ...n brain cells for any adult,neurodegenerative dise...2 patients with,advanced Parkinson,s disease demon...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6
Safety Blood Collection Sets are supplied in three packaging variations, either with or without Luer Adapter and respectively a version with Luer Adapter and Tube Holder.
Simplicity and multi-directional retraction for a broad range of abdominal procedures
Expanded system accommodates the larger patient. Fully-adjustable for any patient and any approach. Blades can be stacked on top of each other in the operative site for body wall and deeper retractio
These retractors are packaged singly ready for sterilization at your facility.
Medicine Products: